Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04349124 · ClinicalTrials.gov registry record · Phase 4
Persistent Postpartum Hypertension Pilot Trial
A Phase 4 study, sponsored by Duke University.
- Terminated
- Registry status
- Phase 4
- Development phase
- 12
- Enrollment target
NCT04349124 is a Phase 4 study that was terminated before completion, run by Duke University. The registered enrollment target is 12 participants.
The verdict
NCT04349124, a Phase 4 study, was terminated before completion, sponsored by Duke University.
- TERMINATED
- Registry status
- Phase 4
- Development phase
- 12 participants
- Enrollment target
Study Summary
This study is a pilot, open-label, randomized controlled trial of postpartum women with hypertensive disorders pregnancy and persistent non-severe blood pressure. The purpose of the study to provide data that may provide guidance regarding blood pressure management of patients with non-severe postpartum hypertension. There are limited guidelines for best practice with persistent, non-severe hypertension, and treatment in this situation is usually at the provider's discretion.
Interventions
- DRUG Nifedipine Extended-Release Tablets
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2020-08-25 |
| Est. Completion | 2021-03-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04349124
The ClinicalTrials.gov registry entry for NCT04349124 describes a study currently listed as terminated, categorized as Phase 4. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nifedipine Extended-Release Tablets is the first listed.
NCT04349124 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04349124 about?
NCT04349124 is a clinical study titled "Persistent Postpartum Hypertension Pilot Trial". This study is a pilot, open-label, randomized controlled trial of postpartum women with hypertensive disorders pregnancy and persistent non-severe blood pressure. The purpose of the study to provide data that may provide guidance regarding blood pressure management of patients with non-severe postpa...
What is the current status of trial NCT04349124?
This trial is currently terminated. It is a Phase 4 study. The enrollment target is 12 participants. The study started on 2020-08-25. Estimated completion is 2021-03-04.
What interventions are being tested in trial NCT04349124?
The interventions under investigation include: Nifedipine Extended-Release Tablets (DRUG).
Who is sponsoring clinical trial NCT04349124?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.